Targeting LD biogenesis using DGAT1 inhibitor has been proposed in combination with chemotherapy to increase cell death in prostate cancer [41] or to promote ferroptosis during tumor acidosis [42]. The gene discussed is DGAT1; the disease is prostate cancer.